Composite
Part:BBa_K2923019:Experience
Designed by: Kateryna LEN Group: iGEM19_Strasbourg (2019-10-13)
Introduction
To validate the designed constructs we decided to test two different aptazymes: Theophylline switch-off (stop auto-cleavage in presence of ligand) and Guanine switch-on (active auto-cleavage in presence of ligand). For negative control, we choose an inactive form of aptazyme: mutation at the ribozyme domain. iGEM Strasbourg designed construct requires the use of aptazyme linked to MS2 and PP7 stem-loops. The following results described MS2-MS2-Aptazyme-PP7-PP7 activity in in-vitro and in-vivo assays.
In-vitro assay of BBa_K2923018
In order to check MS2-MS2-Guanine-PP7-PP7 cleavage activities, in-vitro transcription products were analyzed by 2% agarose gel with urea (Figure 1).
User Reviews
UNIQd7266e072ee91ae2-partinfo-00000000-QINU UNIQd7266e072ee91ae2-partinfo-00000001-QINU